Nolato AB Series B | Cash Flow

Fiscal year is January-December. All values SEK Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
411,000.00
454,000.00
556,000.00
443,000.00
749,000.00
941,000
Depreciation, Depletion & Amortization
157,000.00
165,000.00
181,000.00
193,000.00
231,000.00
248,000
Other Funds
117,000.00
81,000.00
185,000.00
129,000.00
81,000.00
229,000
Funds from Operations
451,000.00
538,000.00
552,000.00
507,000.00
899,000.00
960,000
Changes in Working Capital
61,000.00
208,000.00
20,000.00
41,000.00
126,000.00
85,000
Net Operating Cash Flow
512,000.00
330,000.00
532,000.00
466,000.00
773,000.00
1,045,000
Capital Expenditures
151,000.00
204,000.00
246,000.00
223,000.00
279,000.00
Sale of Fixed Assets & Businesses
7,000.00
1,000.00
2,000.00
2,000.00
2,000.00
Net Investing Cash Flow
144,000.00
203,000.00
244,000.00
619,000.00
277,000.00
Cash Dividends Paid - Total
158,000.00
210,000.00
224,000.00
263,000.00
276,000.00
Issuance/Reduction of Debt, Net
169,000.00
17,000.00
86,000.00
420,000.00
49,000.00
Net Financing Cash Flow
327,000.00
227,000.00
138,000.00
157,000.00
222,000.00
Net Change in Cash
46,000.00
62,000.00
147,000.00
8,000.00
258,000.00
Free Cash Flow
361,000.00
126,000.00
286,000.00
243,000.00
499,000.00
Net Assets from Acquisitions
-
-
-
398,000.00
-
Change in Capital Stock
-
-
-
-
5,000.00
Exchange Rate Effect
5,000.00
38,000.00
3,000.00
4,000.00
16,000.00

About Nolato AB

View Profile
Address
Nolatovägen
Torekov SN 269 04
Sweden
Employees -
Website http://www.nolato.com
Updated 07/08/2019
Nolato AB engages in the development and manufacture of polymer product systems for customers in medical technology, telecommunications, hygiene, automotive products and other selected industrial sectors. It operates through the following segments: Medical Solutions, Integrated Solutions, and Industrial Solutions. The Medical Solutions segment develops and manufactures complex product systems and components within medical technology, as well as advanced packaging solutions for pharmaceuticals and dietary supplements.